The impact of alpha-1 antitrypsin augmentation therapy on neutrophil-driven respiratory disease in deficient individuals

Danielle M Dunlea, Laura T Fee, Thomas McEnery, Noel G McElvaney, Emer P Reeves Irish Centre for Genetic Lung Disease, Department of Medicine, Royal College of Surgeons in Ireland, Beaumont Hospital, Dublin, Ireland Abstract: Alpha-1 antitrypsin (AAT) is the most abundant serine protease inhibitor c...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Dunlea DM, Fee LT, McEnery T, McElvaney NG, Reeves EP
Format: article
Langue:EN
Publié: Dove Medical Press 2018
Sujets:
Accès en ligne:https://doaj.org/article/f1620ab2eb794c16b3c4e4484422dd48
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!